Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radiotherapy-Induced Immune Priming”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07467590
What this trial is testing

Combination of High and Low-Dose Radiotherapy With Immune Therapy and TKI in Advanced Colorectal Cancer: A Phase II Study

Who this might be right for
Refractory Colorectal CancerRadiotherapy-Induced Immune PrimingImmune Response
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 33
Not applicableActive Not RecruitingNCT03978663
What this trial is testing

Three Fraction Radiation to Induce Immuno-Oncologic Response

Who this might be right for
High-Risk CancerLocally Advanced Breast Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 40
Testing effectiveness (Phase 2)Looking for participantsNCT07382739
What this trial is testing

Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Multiple Myeloma (RRMM) With Extramedullary Disease (EMD) and Paramedullary Disease (PMD) "PRIME-EMD-PMD"

Who this might be right for
Phase 2Radiotherapy-Induced Immune PrimingElranatamab+4 more
M.D. Anderson Cancer Center 34